Do not take 2 doses of dulaglutide within 3 days of each other
Section 15: Inpatient management of type 1 diabetes There have been no large RCTs specifically assessing glycaemic targets for inpatients with type 1 diabetes
Everard, A
doi: 10.3389/fphar.2022.856111 Received 16 January 2022 Accepted 15 February 2022 Published 08 March 2022 Volume 13 - 2022 Edited by Giuseppe Paolisso, University of Campania Luigi Vanvitelli, Italy Reviewed by Stefano Ciardullo, University of Milano Bicocca, Italy Maria Rosaria Rizzo, University of Campania Luigi Vanvitelli, Italy Updates Copyright 2022 Pahud de Mortanges, Sinaci, Salvador, Bally, Muka, Wilhelm and Bano
It reduces appetite, slows gastric emptying, improves insulin sensitivity, and produces meaningful reductions in body weight over time
This minor difference results in the inability of IGF-1 Des to bind with insulin-like growth factor binding proteins (IGFPB) present in plasma and tissues, making it more available for receptors compared to IGF-1